APLS vs XLV
Apellis Pharmaceuticals Inc (APLS) versus Health Care Select Sector SPDR® Fund (XLV) — a side-by-side from cached financials, not a winner call.
Apellis Pharmaceuticals Inc (APLS) is a biotechnology company listed on US.
Health Care Select Sector SPDR® Fund (XLV) common stock listed on US.
Latest reported APLS revenue for 2025-12-31 was $1.00B. Net income was $22.4M. Revenue was up 28.5% from 2024-12-31 to 2025-12-31. APLS currently screens at market cap $2.29B.
XLV does not have a complete income-statement cache yet.
APLS currently screens at market cap $2.29B. XLV currently screens at market cap $0.
Not investment advice. Open the APLS and XLV stock pages for the full models.
Not investment advice.